Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergence of Hepatitis C Virus Genotype Recombinant Forms 2k/1b in Georgia.
Zakalashvili M, Weizenegger M, Bartel J, Markowski M, Zarqua J, Kavsadze S, Kvatadze K, Basheleishvili G, Phirtskhalaishvili T, Dzagania T, Zangurashvili L, Kankia N, Jashiashvili N, Lomidze M, Telia T, Kerashvili V, Zhamutashvili M, Abramishvili N, Rtskhiladze I, Metreveli D. Zakalashvili M, et al. Clin Lab. 2016 Jul 1;62(7):1347-1351. doi: 10.7754/Clin.Lab.2016.151210. Clin Lab. 2016. PMID: 28164650
Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.
Zakalashvili M, Zarkua J, Weizenegger M, Bartel J, Raabe M, Zangurashvili L, Kankia N, Jashiashvili N, Lomidze M, Telia T, Kerashvili V, Zhamutashvili M, Abramishvili N, Hedskog C, Chodavarapu K, Brainard DM, McHutchison JG, Mo H, Svarovskaia E, Gish RG, Rtskhiladze I, Metreveli D. Zakalashvili M, et al. Liver Int. 2018 Mar;38(3):451-457. doi: 10.1111/liv.13540. Epub 2017 Sep 2. Liver Int. 2018. PMID: 28782185
Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study.
Walker JG, Kuchuloria T, Sergeenko D, Fraser H, Lim AG, Shadaker S, Hagan L, Gamkrelidze A, Kvaratskhelia V, Gvinjilia L, Aladashvili M, Asatiani A, Baliashvili D, Butsashvili M, Chikovani I, Khonelidze I, Kirtadze I, Kuniholm MH, Otiashvili D, Sharvadze L, Stvilia K, Tsertsvadze T, Zakalashvili M, Hickman M, Martin NK, Morgan J, Nasrullah M, Averhoff F, Vickerman P. Walker JG, et al. Among authors: zakalashvili m. Lancet Glob Health. 2020 Feb;8(2):e244-e253. doi: 10.1016/S2214-109X(19)30483-8. Epub 2019 Dec 18. Lancet Glob Health. 2020. PMID: 31864917 Free PMC article.
Integration of hepatitis C treatment at harm reduction centers in Georgia-Findings from a patient satisfaction survey.
Butsashvili M, Kamkamidze G, Kajaia M, Gvinjilia L, Kuchuloria T, Khonelidze I, Gogia M, Dolmazashvili E, Kerashvili V, Zakalashvili M, Shadaker S, Nasrullah M, Sonjelle S, Japaridze M, Averhoff F. Butsashvili M, et al. Among authors: zakalashvili m. Int J Drug Policy. 2020 Oct;84:102893. doi: 10.1016/j.drugpo.2020.102893. Epub 2020 Jul 31. Int J Drug Policy. 2020. PMID: 32739613 Free PMC article.
Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries.
Boeke CE, Hiebert L, Waked I, Tsertsvadze T, Sharvadze L, Butsashvili M, Zakalashvili M, Naing W, Gupta N, Kateera F, McClure C, Ward JW, Ramers CB. Boeke CE, et al. Among authors: zakalashvili m. Clin Infect Dis. 2022 Feb 11;74(3):513-516. doi: 10.1093/cid/ciab461. Clin Infect Dis. 2022. PMID: 34014252 Free PMC article.
Association of Treated and Untreated Chronic Hepatitis C With the Incidence of Active Tuberculosis Disease: A Population-Based Cohort Study.
Baliashvili D, Blumberg HM, Benkeser D, Kempker RR, Shadaker S, Averhoff F, Gvinjilia L, Adamashvili N, Magee M, Kamkamidze G, Zakalashvili M, Tsertsvadze T, Sharvadze L, Chincharauli M, Tukvadze N, Gandhi NR. Baliashvili D, et al. Among authors: zakalashvili m. Clin Infect Dis. 2023 Jan 13;76(2):245-251. doi: 10.1093/cid/ciac786. Clin Infect Dis. 2023. PMID: 36134743 Free PMC article.
16 results